Trifecta Capital Advisors, LLC
Source: SEC Form 13F · as of Mar 2026Trifecta Capital Advisors, LLC holds 19 biotech & pharma companies tracked by BioSniper, totaling $48.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$48.6M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 25,631 | $23.6M |
| ABBVAbbVie Inc. | 40,702 | $8.9M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 16,757 | $7.5M |
| AMGNAMGEN INC | 15,992 | $5.6M |
| JNJJOHNSON & JOHNSON | 3,947 | $965K |
| MRKMerck & Co., Inc. | 5,723 | $688K |
| GILDGILEAD SCIENCES, INC. | 3,190 | $445K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 785 | $212K |
| MCKMcKesson Corporation | 200 | $173K |
| ABTABBOTT LABORATORIES | 1,664 | $171K |
| NVONovo Nordisk A/S | 4,016 | $148K |
| IDXXIDEXX LABORATORIES INC /DE | 160 | $90K |
| ZTSZoetis Inc. | 600 | $71K |
| DRTSAlpha Tau Medical Ltd. | 9,700 | $69K |
| TWSTTwist Bioscience Corp | 475 | $23K |
| ARMPArmata Pharmaceuticals, Inc. | 714 | $7K |
| BYSIBeyondSpring Inc. | 1,500 | $2K |
| GEHCGE HealthCare Technologies Inc. | 4 | $285 |
| RIOTRiot Platforms, Inc. | 22 | $272 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.